A5039216883- Hepatitis B Virus Studies
- Hepatitis C virus research
- Liver Disease Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Hepatitis Viruses Studies and Epidemiology
- Biochemical and Molecular Research
- Neutropenia and Cancer Infections
- Pneumocystis jirovecii pneumonia detection and treatment
- Cytomegalovirus and herpesvirus research
- Cancer Risks and Factors
- Cervical Cancer and HPV Research
- Circular RNAs in diseases
- Extracellular vesicles in disease
- Global Cancer Incidence and Screening
- MicroRNA in disease regulation
- Hematological disorders and diagnostics
- HIV/AIDS drug development and treatment
Nanjing Medical University
2018-2023
Nanfang Hospital
2006-2013
Pusan National University
2013
Southern Medical University
2013
University of Toronto
2009
Gilead Sciences (United States)
2009
Changchun Obstetrics and Gynecology Hospital
2009
Chang Gung University
2009
Chang Gung Memorial Hospital
2009
Beijing Ditan Hospital
2007
The World Health Organization has proposed a 65% reduction in viral hepatitis-related mortality by 2030, and the key to achieve this ambitious goal is reduce from hepatocellular carcinoma (HCC). HCC second leading cause of death patients with malignant tumors China. Notably, one important links risk based on factors very early warning biomarkers. Therefore, constructing prediction model, accurately identifying high-risk population, developing an individualized screening strategy, may improve...